Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trialYaseen M. Arabi, Katrina Orr, Lise J Estcourt et al.|Intensive Care Medicine|2021Cited by 100